These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6839959)

  • 41. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver damage induced by coumarin anticoagulants.
    Ehrenforth S; Schenk JF; Scharrer I
    Semin Thromb Hemost; 1999; 25(1):79-83. PubMed ID: 10327225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible warfarin resistance due to interaction with ascorbic acid: case report and literature review.
    Sattar A; Willman JE; Kolluri R
    Am J Health Syst Pharm; 2013 May; 70(9):782-6. PubMed ID: 23592361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
    Bern M
    JPEN J Parenter Enteral Nutr; 2004; 28(6):388-98. PubMed ID: 15568285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bilateral Phlegmasia Cerulea Dolens After Warfarin Reversal for Acute Rectal Bleeding: A Case Report.
    Fong B; Novak D; Dalley M; Alfred G
    J Emerg Med; 2018 Apr; 54(4):533-536. PubMed ID: 29449120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
    Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
    Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Warfarin resistance in a French strain of rats.
    Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E
    J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Warfarin therapy in children who require long-term total parenteral nutrition.
    Newall F; Barnes C; Savoia H; Campbell J; Monagle P
    Pediatrics; 2003 Nov; 112(5):e386. PubMed ID: 14595081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis.
    Bona RD; Hickey AD; Wallace DM
    Am J Clin Oncol; 2000 Feb; 23(1):71-3. PubMed ID: 10683083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Remission of refractory chronic cluster headache after warfarin administrations: case report.
    Souza JA; Moreira Filho PF; Jevoux Cda C; Martins GF; Pitombo AB
    Arq Neuropsiquiatr; 2004 Dec; 62(4):1090-1. PubMed ID: 15608975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Warfarin therapy and chlorella].
    Ohkawa S; Yoneda Y; Ohsumi Y; Tabuchi M
    Rinsho Shinkeigaku; 1995 Jul; 35(7):806-7. PubMed ID: 8777808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
    Self TH; Oliphant CS; Reaves AB; Richardson AM; Sands CW
    Thromb Res; 2015 Jan; 135(1):5-8. PubMed ID: 25456000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Changed warfarin tolerance].
    Johannessen H
    Tidsskr Nor Laegeforen; 1973 Jun; 93(16):1236-9. PubMed ID: 4584765
    [No Abstract]   [Full Text] [Related]  

  • 55. Will there be a role for genotyping in warfarin therapy?
    Gandara E; Wells PS
    Curr Opin Hematol; 2010 Sep; 17(5):439-43. PubMed ID: 20601874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
    Bala A; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Clin Orthop Relat Res; 2017 Sep; 475(9):2205-2213. PubMed ID: 28569372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genetic basis of resistance to anticoagulants in rodents.
    Pelz HJ; Rost S; Hünerberg M; Fregin A; Heiberg AC; Baert K; MacNicoll AD; Prescott CV; Walker AS; Oldenburg J; Müller CR
    Genetics; 2005 Aug; 170(4):1839-47. PubMed ID: 15879509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Resistance to vitamin K antagonists. 6 cases].
    Lefrère JJ; Guyon F; Horellou MH; Conard J; Samama M
    Ann Med Interne (Paris); 1986; 137(5):384-90. PubMed ID: 3813270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
    Bian C; Qi X; Li L; Zhao J; Liu X
    Arch Gynecol Obstet; 2016 Jan; 293(1):69-74. PubMed ID: 26048261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    Eek AK; Øie E; Granas AG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.